(R)-2-(2-CHLORO-5-FLUOROPHENYL)PYRROLIDINE, 95.0%, 1g

2-chloro-6,7-dimethoxy-1,4-dihydroquinazolin-4-one, 97%, 100mg

1-Bromo-3-(isopropylsulfanyl)benzene, 5g

ethyl 3-{[3-(dimethylamino)-2,2-dimethylpropyl]amino}propanoate, 95.0%, 10g

Cyclopropyl(pyridin-2-yl)methanamine, 95.0%, 5g

trans-3-Hexenedioic Acid>98.0%(T)5g

(R)-(-)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)dimethylamine>98.0%(HPLC)(N)5g

5H-Dibenzo[b,d]azepin-6(7H)-one, 95.0%, 1g

6,7-DIHYDRO-1-METHYL-PYRROLO[2,3-C]AZEPINE-4,8(1H,5H)-DIONE, 95.0%, 250mg

N-(3-Aminopropyl)carbamic acid tert-butyl ester, 96.0%, 25g

2-Methyl-3-pyridinylboronic acid, 95.0%, 5g

tert-Butyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate, 97%, 500mg

TRANS-4-(1-NAPHTHYL)PYRROLIDINE-3-CARBOXYLIC ACID HCL, 95.0%, 1g